优化治疗抑郁症在初级保健使用心理治疗对抗抑郁药物治疗在低资源设置:优化D随机对照试验的协议
Research square
|June 5, 2025
概括
这项研究调查了印度个性化的抑郁症治疗方法,比较行为激活疗法和药物治疗. 机器学习将预测最佳治疗方法,以改善患者在初级保健中的治疗结果.
科学领域:
- 心理健康研究 心理健康研究
- 临床试验 临床试验
- 医疗保健中的机器学习
背景情况:
- 抑郁症治疗的有效性在患者之间有很大差异.
- 个性化治疗选择至关重要,特别是在资源较少的环境中.
- 优化抑郁症 (OptimizeD) 试验解决了初级保健中的这一差距.
研究的目的:
- 为了确定患者对行为激活疗法与抗抑郁药物的反应是否不同.
- 用机器学习开发精确的治疗规则,以获得最佳的抑郁症护理.
- 评估个性化治疗策略的成本效益.
主要方法:
- 随机选择印度1500名中度至重度抑郁症患者.
- 将文化适应的行为激活疗法 (健康活动计划) 与素相比较.
- 利用各种基线数据的机器学习来预测治疗缓解.
主要成果:
- 主要终点:3个月后抑郁症缓解 (PHQ-9分数<5).
- 机器学习模型将预测最佳的治疗分配.
- 成本效益分析将评估治疗优化效益.
结论:
- 基线数据可以指导初级保健中最佳抑郁症治疗选择.
- 不响应的预测可以促进及时的专家转诊.
- 这些发现可能会在全球范围内加强个性化抑郁症护理,特别是在资源有限的地区.
相关概念视频
Treatment Strategies for Psychological Disorders
288
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
288
Antidepressant Drugs: MAOIs and Other Agents
380
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
380
Electroconvulsive Therapy
205
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
205
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Antidepressant Drugs: Overview
804
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
804
Psychosis: Goals of Pharmacotherapy
216
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
216


